Here's why Roche might buy Watertown's Tetraphase — and why Cubist probably won't
November 26, 2014 at 11:55 AM EST
On Monday, Bloomberg cited unnamed sources in reporting that antibiotics developer Tetraphase is considering a sale to one of two Swiss drug giants...